Latest Nzx Listings News

Locate Technologies reported steady Q1 FY26 revenue with a strategic pivot to the NZX to better support its Bitcoin treasury ambitions. The company’s Locate2u unit showed promising growth, while Zoom2u faced challenges amid softer consumer spending.

Locate Technologies reports a 19% revenue increase in its Locate2u segment and progresses toward a December 2025 NZX listing, supported by new board appointments and a NZD 10 million ATM facility.

Finaccess Restauración, S.L. has launched a formal, unconditional takeover offer for all remaining shares of Restaurant Brands New Zealand Limited at NZ$5.05 per share, representing a substantial premium over recent trading prices.

Uvre Limited has gained approval for a secondary listing on the New Zealand Stock Exchange, complementing its ASX listing and enhancing access to New Zealand investors. This move aligns with its expanding gold exploration projects across New Zealand.

Manuka Resources has gained approval for a secondary listing on the New Zealand Stock Exchange, enhancing trading access for local shareholders and supporting its strategic growth in critical and precious metals projects across New Zealand and Australia.

Locate Technologies plans to transfer its listing from the ASX to the New Zealand Exchange, aiming to unlock greater flexibility for its Bitcoin Treasury Strategy. Shareholders will exchange their shares for NZX-listed equivalents, with the transition expected by late November 2025.

Metro Performance Glass is set to strengthen its balance sheet and support its turnaround strategy through a $15 million to $24 million equity raise, with Amari Metals Australia poised to become the majority shareholder. This recapitalisation aims to reduce debt and improve operational focus amid challenging market conditions.

Turners Automotive Group has issued over 324,000 new shares under its Dividend Reinvestment Plan for the FY25 final dividend, slightly increasing its capital base.

TruScreen Limited has obtained a waiver from NZ RegCo allowing it to allot oversubscribed shares up to 10 business days after its capital raising offer closes, subject to shareholder approval. This move aims to streamline the company’s NZ$3 million placement and share purchase plan.

TruScreen Ordinary Shares Group Limited has announced a combined share purchase plan and placement to raise approximately NZD 1.78 million, aiming to accelerate its international expansion and cervical cancer screening initiatives.

AFT Pharmaceuticals reported a 6% increase in revenue to NZ$208 million for the year ending March 2025, but net profit fell 23%, prompting a modest final dividend declaration.